King & Wood Mallesons has hired a former Paul Hastings partner as counsel in Hong Kong.

Jason Kuo specializes in capital markets deals. He advises on the U.S. law aspects of Hong Kong listings and relevant transactions. Last year, he represented Hong Kong-based biopharmaceutical company SinoMab BioScience Ltd. on a $177 million initial public offering.